Lewicki John A. has filed 13 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 139913 shares of Mereo BioPharma Group plc ($MREO) on February 01, 2026.
Activity breakdown: 0 open-market purchases and 4 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 1, 2026 | Mereo BioPharma Group plc | $MREO | Lewicki John A. | Chief Scientific Officer | A | Share Options (Right to buy) | 139913 | $0.00 | 139,913.0000 | 799,947,013 | 9999.99% | 0.02% |
| Feb. 1, 2026 | Mereo BioPharma Group plc | $MREO | Lewicki John A. | Chief Scientific Officer | A | Share Options (Right to buy) | 145000 | $0.00 | 145,000.0000 | 799,947,013 | 9999.99% | 0.02% |
| Feb. 1, 2026 | Mereo BioPharma Group plc | $MREO | Lewicki John A. | Chief Scientific Officer | A | Share Options (Right to buy) | 46637 | $0.00 | 46,637.0000 | 799,947,013 | 9999.99% | 0.01% |
| Jan. 25, 2025 | Mereo BioPharma Group plc | $MREO | Lewicki John A. | Chief Scientific Officer | A | Share Options (Right to buy) | 116000 | $0.00 | 116,000.0000 | 739,624,264 | 9999.99% | 0.02% |
| Sept. 13, 2024 | Mereo BioPharma Group plc | $MREO | Lewicki John A. | Chief Scientific Officer | S | American Depositary Shares representing Ordinary Shares | 10937 | $4.22 | 92,826.0000 | 770,146,589 | 10.54% | 0.00% |
| Sept. 12, 2024 | Mereo BioPharma Group plc | $MREO | Lewicki John A. | Chief Scientific Officer | S | American Depositary Shares representing Ordinary Shares | 5212 | $4.47 | 103,763.0000 | 770,146,589 | 4.78% | 0.00% |
| Sept. 11, 2024 | Mereo BioPharma Group plc | $MREO | Lewicki John A. | Chief Scientific Officer | M | Performance Based Restricted Stock Unit | 46000 | $0.00 | 0.0000 | 770,146,589 | 100.00% | 0.01% |
| Sept. 11, 2024 | Mereo BioPharma Group plc | $MREO | Lewicki John A. | Chief Scientific Officer | M | American Depositary Shares representing Ordinary Shares | 46000 | $0.00 | 108,975.0000 | 770,146,589 | 73.04% | 0.01% |
| June 25, 2024 | Mereo BioPharma Group plc | $MREO | Lewicki John A. | Chief Scientific Officer | S | American Depositary Shares representing Ordinary Shares | 7416 | $3.69 | 79,783.0000 | 659,453,921 | 8.50% | 0.00% |
| June 26, 2024 | Mereo BioPharma Group plc | $MREO | Lewicki John A. | Chief Scientific Officer | S | American Depositary Shares representing Ordinary Shares | 16808 | $3.39 | 62,975.0000 | 659,453,921 | 21.07% | 0.00% |
| June 21, 2024 | Mereo BioPharma Group plc | $MREO | Lewicki John A. | Chief Scientific Officer | M | Performance Based Restricted Stock Unit | 69000 | $0.00 | 46,000.0000 | 659,453,921 | 0.00% | 0.01% |
| June 21, 2024 | Mereo BioPharma Group plc | $MREO | Lewicki John A. | Chief Scientific Officer | M | American Depositary Shares representing Ordinary Shares | 69000 | $0.00 | 87,199.0000 | 659,453,921 | 379.14% | 0.01% |
| Jan. 25, 2024 | Mereo BioPharma Group plc | $MREO | Lewicki John A. | Chief Scientific Officer | A | Share Options (Right to buy) | 137000 | $0.00 | 137,000.0000 | 659,453,921 | 9999.99% | 0.02% |